跳至主要内容
临床试验/NCT00680238
NCT00680238已完成不适用

Pregnancy and Implantation Rates When Embryos Are Selected Based on a Single Day 3 Score (Day 3)vs Graduated Embryo Score(GES) Plus Soluble Human Leukocyte Antigen-G Expression.

University of Stellenbosch0 个研究点目标入组 214 人开始时间: 2004年6月最近更新:
适应症
干预措施
相关药物

试验速览

阶段
不适用
状态
已完成
入组人数
214
主要终点
Pregnancy and implantation rates

研究概览

简要总结

Objective: To compare pregnancy rates and implantation rates when embryos are selected based on a single Day 3 (D.3) score vs. a GES score plus sHLA-G expression.

详细描述

Comparing pregnancy rates and implantation rates when embryos are selected using the most common criteria for embryo selection on day 3 - the morphology-(number of blastomere, their shape and size and the percentage of fragmentation)vs a graduated embryo score accumulated over 72 hours and the expression of sHLA-G at 44-46 hours post fertilization.

研究设计

研究类型
Interventional
分配方式
Randomized
干预模型
Parallel
盲法
Single (Participant)

入排标准

年龄范围
25 Years 至 40 Years(Adult)
性别
Female
接受健康志愿者

入选标准

  • Self paying ART patients

排除标准

  • Abnormal uterus
  • Specific Immunologic factors

研究组 & 干预措施

A

No Intervention

Embryo selection for transfer based on a Day 3 score only.

干预措施: Human derived FSH (Drug)

B

Active Comparator

Embryos for transfer by first selecting any embryos that had a positive sHLA-G expression of OD = 190 ±6 and correlating such with the highest GES score available.

干预措施: Human derived FSH (Drug)

结局指标

主要结局

Pregnancy and implantation rates

时间窗: 12 weeks

次要结局

  • Miscarriage rates(9-11 day until βhCG)

研究者

申办方类型
Other

相似试验